Labiana Health (XMAD:LAB) Price-to-Tangible-Book: (As of Jul. 23, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XMAD:LAB Labiana Health SA XMAD:LAB
57 GF Score
Price €6.55
GF Value €3.60
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Labiana Health Price-to-Tangible-Book?

As of today (2026-07-23), Labiana Health's share price is €6.55. Labiana Health's Tangible Book per Share of Dec. 2025 for the quarter that ended in Dec. 2025 was €-0.16. Hence, Labiana Health's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Labiana Health's Price-to-Tangible-Book or its related term are showing as below:

XMAD:LAB's Price-to-Tangible-Book is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.165
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Labiana Health's share price is €6.55. Labiana Health's Book Value per Sharefor the quarter that ended in Dec. 2025 was €0.71. Hence, Labiana Health's P/B Ratio of today is 9.24.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Labiana Health Price-to-Tangible-Book Related Terms


Labiana Health Price-to-Tangible-Book Historical Data

* Premium members only.

The historical data trend for Labiana Health's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Labiana Health Price-to-Tangible-Book Chart

Labiana Health Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Price-to-Tangible-Book
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Labiana Health Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

XMAD:LAB vs ZTS, UTHR, VTRS: Price-to-Tangible-Book Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Labiana Health's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Labiana Health Price-to-Tangible-Book vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Labiana Health's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Labiana Health's Price-to-Tangible-Book falls into.


XMAD:LAB
57GF Score
Labiana Health SA XMAD:LAB
Price-to-Tangible-Book is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Labiana Health Price-to-Tangible-Book Calculation

Labiana Health's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2025 )
=6.55/-0.155
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Is Labiana Health (XMAD:LAB) Overvalued in 2026?

Based on GuruFocus' analysis, Labiana Health stock appears to be overvalued. The current stock price of €6.55 is trading 81.9% above its estimated GF Value™ of €3.60. GuruFocus considers Labiana Health to be Significantly Overvalued.

Key valuation signals for XMAD:LAB:

  • Price-to-Tangible-Book:
  • GF Value™: €3.60 vs. price of €6.55 (81.9% above fair value)
  • GF Score™: 57/100 with 3 warning signs

No single metric tells the full story. See the XMAD:LAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Labiana Health Business Description

Other Exchanges 8RK:Germany
Address Avenida Europa, 34 1st D, Pozuelo de Alarcon, Madrid, ESP, 28023
Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include a GMP manufacturer for EU animal and human health industries, a manufacturer specializing in sterile and lyophilized dosage forms, and a source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol. The company operates in two segment Animal Health and Human Health.
57GF Score

Get the complete analysis for XMAD:LAB

Price-to-Tangible-Book is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.55
Price
€3.60
GF Value